Apolo Balyegisawa

Affiliations
  • Infectious Diseases Institute, Makerere University, Kampala, Uganda.

Publications (2)

Efficacy and safety of dolutegravir or darunavir in combination with lamivudine plus either zidovudine or tenofovir for second-line treatment of HIV infection (NADIA): week 96 results from a prospective, multicentre, open-label, factorial, randomised, non-inferiority trial.

The lancet. HIV
Avec: Nicholas I Paton , Joseph Musaazi , Cissy Kityo , Stephen Walimbwa , Anne Hoppe , Apolo Balyegisawa , Jesca Asienzo , Arvind Kaimal , Grace Mirembe , Abbas Lugemwa , Gilbert Ategeka , Margaret Borok , Henry Mugerwa , Abraham Siika , Eva Laker A Odongpiny , Barbara Castelnuovo , Agnes Kiragga , Andrew Kambugu , Auteur inconnu

Dolutegravir or Darunavir in Combination with Zidovudine or Tenofovir to Treat HIV.

The New England journal of medicine
Avec: Nicholas I Paton , Joseph Musaazi , Cissy Kityo , Stephen Walimbwa , Anne Hoppe , Apolo Balyegisawa , Arvind Kaimal , Grace Mirembe , Phionah Tukamushabe , Gilbert Ategeka , James Hakim , Henry Mugerwa , Abraham Siika , Jesca Asienzo , Barbara Castelnuovo , Agnes Kiragga , Andrew Kambugu , Auteur inconnu

Réseau de co-auteurs

Nicholas I Paton 2 collaborations
Joseph Musaazi 2 collaborations
Cissy Kityo 2 collaborations
Stephen Walimbwa 2 collaborations
Anne Hoppe 2 collaborations
Jesca Asienzo 2 collaborations
Arvind Kaimal 2 collaborations
Grace Mirembe 2 collaborations
Gilbert Ategeka 2 collaborations
Henry Mugerwa 2 collaborations
Abraham Siika 2 collaborations
Barbara Castelnuovo 2 collaborations
Agnes Kiragga 2 collaborations
Andrew Kambugu 2 collaborations
None None 2 collaborations
Abbas Lugemwa 1 collaboration
Margaret Borok 1 collaboration
Eva Laker A Odongpiny 1 collaboration
Phionah Tukamushabe 1 collaboration
James Hakim 1 collaboration